Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Behçet's disease

OBJECTIVES: There is an increasing need to identify reliable biomarkers for distinguishing Crohn’s disease (CD) from other gastrointestinal disorders sharing similar clinical and pathological features. This study aimed at evaluating the diagnostic potential of antibodies to zymogen granule glycoprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shulan, Luo, Jing, Wu, Ziyan, Roggenbuck, Dirk, Schierack, Peter, Reinhold, Dirk, Li, Ji, Zeng, Xiaofeng, Zhang, Fengchun, Qian, Jiaming, Li, Yongzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830545/
https://www.ncbi.nlm.nih.gov/pubmed/29446764
http://dx.doi.org/10.1038/ctg.2018.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830545/
https://www.ncbi.nlm.nih.gov/pubmed/29446764
http://dx.doi.org/10.1038/ctg.2018.1

Ejemplares similares